IMPLANT SITE DERMATITIS

IMPLANT SITE DERMATITIS was reported 18 times

IMPLANT SITE DERMATITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 10 0.0000
1 Complement Inhibitor [EPC] 1 0.0000
2 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
3 Leukocyte Growth Factor [EPC] 1 0.0000
4 Platinum-based Drug [EPC] 1 0.0000